Skip to main content

Table 1 Chronic co-morbidities at 10% or greater prevalence among the 42 participants

From: High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series

Category or Condition

Number

Percent

Chronic pain syndromes (any)

31

74%

   Extremity pain

17

40%

   Headache (all but one with migraine)

16

38%

   Abdomen

15

36%

   Complex regional pain syndrome

5

12%

Gastrointestinal dysmotility (any)

31

74%

   Gastroesophageal reflux disease and/or chronic nausea

23

55%

   Colonic (irritable bowel syndrome, constipation, diarrhea)

17

40%

Other functional or autonomic-related conditions (any)

24

57%

   Abnormal heart rate

11

26%

   Abnormal temperature regulation

7

17%

   Dizziness

6

14%

   Tinnitus

5

12%

Mental health disorders (any)

13

31%

   Depression

10

24%

All cognitive disorders (any, including attention deficit)

15

36%

   Mental retardation or learning disabilities

13

31%

   Autistic spectrum disorder

4

10%

Other conditions

  

   Any neuromuscular disorder (non cognitive)

18

43%

   Chronic fatigue or exercise intolerance

23

55%